Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Novo Nordisk provided sponsorship for the development and production of this guide but has had no input into the content Executive Summary This Best Practice Guide offers an overview as well as the details of the opportunities and complexities associated with designing and implementing group consultations for commencement of GLP-1 RA therapy in primary or secondary care
Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study
Many of the clinical studies relied on retrospective analyses, which are subject to selection bias and unmeasured confounders
This material is supplied strictly for in vitro and laboratory use, not for administration to humans or animals
2019 Rogue Rx Activity Report
US$ 20.39
US$ 24.11
US$ 25.25
US$ 28.44
US$ 26.13
